Komori
Presentation materials for financial results4202Daicel CorporationMaterials and Chemicals

Third-Quarter Financial Results Presentation for the Fiscal Year Ended March 2025

For the first 3 quarters of the fiscal year ended March 2025, revenue increased 4.4% year on year to ¥432.5 billion, while operating income declined 2.8% to ¥43.2 billion. Revenue and operating income were progressing roughly in line with the company’s expectations.

Worth reading
59In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
183
¥100 million (year-on-year change in revenue)
Wording
Conditional
How definitive the wording is.

Contents of this document

Presentation materials for financial results2025年3月期 第3四半期8 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales4,325 Hundreds of millions of yen+4.4%
Operating profit432 Hundreds of millions of yen-2.8%
Ordinary income448 Hundreds of millions of yen-7.0%
Net income¥440 100 million -0.4%quarterly net income attributable to owners of the parent
Results for the three months of the current quarter
2025年3月期第3四半期単独。セグメント別および合計の数値
Net Sales
1,429 Hundreds of millions of yen
Operating profit
116 Hundreds of millions of yen
Full-year earnings forecast
Net Sales
6,000 Hundreds of millions of yen
Operating profit
600 Hundreds of millions of yen
Ordinary income
600 Hundreds of millions of yen
Profit attributable to owners of the parent
510 Hundreds of millions of yen
Annual Dividend
¥60 per share
Progress against full-year forecast　通期の予想に対して、いまどこまで進んだかの割合です。
Consolidated
Net Sales72.1%
Operating profit72.1%
Ordinary income74.7%
Profit attributable to owners of parent for the quarter86.4%
By segment
Net Sales
Medical and Healthcare72.6%
Smart74.9%
Safety72.8%
Materials67.6%
Engineering Plastics74.7%
Other Businesses73.6%
Operating profit
Medical and Healthcare52.2%
Safety58.7%
Materials64.8%
Engineering Plastics85.7%
Other Businesses78.3%
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
売上高、営業利益は想定並みに進捗
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Consolidated revenue
Volume variance+¥7.0 billion
Price variance+113億円
単価差の内為替影響+¥18.3 billion
Consolidated operating profit
Volume impact+¥1.4 billion
Impact on pricing+¥1.9 billion
Other-¥4.6 billion
その他の内為替影響+¥7.3 billion
セグメント営業利益要因各セグメントについて数量影響・価格影響・その他の金額を掲載
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
  • USD/JPY exchange rate
    2025年3月期上期実績153
    2025年3月期下期計画145
  • Asian methanol spot price
    2025年3月期上期実績332
    2025年3月期下期計画320
  • Dubai crude oil
    2025年3月期上期実績82
    2025年3月期下期計画85
  • Domestic naphtha
    2025年3月期上期実績77,950
    2025年3月期下期計画72,000
New initiatives
  • 2024年4月1日付でスマートセグメントとマテリアルセグメントを組織再編
  • 同日付で脂環式エポキシ・カプロラクトン誘導体をマテリアルからスマートへ、TACをスマートからマテリアルへ移管
  • 2024年12月に有機半導体事業から撤退
  • ポリプラスチックスグループのPOM新プラントが2024年11月に稼働開始
Key KPIsA metric the company considers important as a management benchmark.
  • EBITDA735 Hundreds of millions of yen
    Year on year against the same period last year+8.4%
  • USD/JPY exchange rate¥153
    Same-period previous-year figure143
  • Asian methanol spot price327 USD/ton
    Same-period previous-year figure322
Segment results
  • Medical and Healthcare
    Net Sales109 Hundreds of millions of yen (YoY +3.7%)
    Operating profit4 Hundreds of millions of yen (YoY -59.8%)
  • Smart
    Net Sales285 Hundreds of millions of yen (YoY +13.3%)
    Operating profit-6 Hundreds of millions of yen
  • Safety
    Net Sales728 Hundreds of millions of yen (YoY +0.1%)
    Operating profit31 Hundreds of millions of yen (YoY +28.1%)
  • Materials
    Net Sales1,292 Hundreds of millions of yen (YoY -2.4%)
    Operating profit191 Hundreds of millions of yen (YoY -34.4%)
  • Engineering Plastics
    Net Sales1,868 Hundreds of millions of yen (YoY +10.2%)
    Operating profit206 Hundreds of millions of yen (YoY +69.6%)
  • Other Businesses
    Net Sales44 Hundreds of millions of yen (YoY +9.6%)
    Operating profit7 Hundreds of millions of yen (YoY +232.1%)
Annual Dividend
Annual¥60 per share
Interim¥30 per share
End of period¥30 per share
Acquisition of treasury shares
Maximum acquisition amount150
Amount unitHundreds of millions of yen
Maximum number of shares to be acquired1,200
Share unit10,000 shares
Period2024年11月～2025年3月
Contents of this document
ItemDetails
Document typePresentation materials for financial results
Fiscal Period Covered2025年3月期 第3四半期
Net Sales4,325 Hundreds of millions of yen (YoY +4.4%)
Operating profit432 Hundreds of millions of yen (YoY -2.8%)
Ordinary income448 Hundreds of millions of yen (YoY -7.0%)
Net income¥440 100 million (quarterly net income attributable to owners of the parent) (YoY -0.4%)
Results for the three months of the current quarterNet Sales 1,429 Hundreds of millions of yen / Operating profit 116 Hundreds of millions of yen / Subject 2025年3月期第3四半期単独。セグメント別および合計の数値
Full-year earnings forecastNet Sales 6,000 Hundreds of millions of yen / Operating profit 600 Hundreds of millions of yen / Ordinary income 600 Hundreds of millions of yen / Profit attributable to owners of the parent 510 Hundreds of millions of yen / Annual Dividend ¥60 per share
Progress against full-year forecastConsolidated Net Sales 72.1% / Operating profit 72.1% / Ordinary income 74.7% / Profit attributable to owners of parent for the quarter 86.4% / By segment Net Sales Medical and Healthcare 72.6% / Smart 74.9% / Safety 72.8% / Materials 67.6% / Engineering Plastics 74.7% / Other Businesses 73.6% / Operating profit Medical and Healthcare 52.2% / Smart Not disclosed / Safety 58.7% / Materials 64.8% / Engineering Plastics 85.7% / Other Businesses 78.3%
Self-assessment against the plan売上高、営業利益は想定並みに進捗
Segment resultsSegment Medical and Healthcare / Net Sales 109 Hundreds of millions of yen (YoY +3.7%) / Operating profit 4 Hundreds of millions of yen (YoY -59.8%), Segment Smart / Net Sales 285 Hundreds of millions of yen (YoY +13.3%) / Operating profit -6 Hundreds of millions of yen, Segment Safety / Net Sales 728 Hundreds of millions of yen (YoY +0.1%) / Operating profit 31 Hundreds of millions of yen (YoY +28.1%), Segment Materials / Net Sales 1,292 Hundreds of millions of yen (YoY -2.4%) / Operating profit 191 Hundreds of millions of yen (YoY -34.4%), Segment Engineering Plastics / Net Sales 1,868 Hundreds of millions of yen (YoY +10.2%) / Operating profit 206 Hundreds of millions of yen (YoY +69.6%), Segment Other Businesses / Net Sales 44 Hundreds of millions of yen (YoY +9.6%) / Operating profit 7 Hundreds of millions of yen (YoY +232.1%)
Breakdown of Factors Affecting the ChangeConsolidated revenue Volume variance +¥7.0 billion / Price variance +113億円 / 単価差の内為替影響 +¥18.3 billion / Consolidated operating profit Volume impact +¥1.4 billion / Impact on pricing +¥1.9 billion / Other -¥4.6 billion / その他の内為替影響 +¥7.3 billion / セグメント営業利益要因 各セグメントについて数量影響・価格影響・その他の金額を掲載
Key KPIsEBITDA 735 Hundreds of millions of yen, USD/JPY exchange rate ¥153, Asian methanol spot price 327 USD/ton
Assumptions Underlying the Business OutlookItem USD/JPY exchange rate / 2025年3月期上期実績 ¥153 / 2025年3月期下期計画 ¥145, Item Asian methanol spot price / 2025年3月期上期実績 332 USD/ton / 2025年3月期下期計画 320 USD/ton, Item Dubai crude oil / 2025年3月期上期実績 82 USD/bbl / 2025年3月期下期計画 85 USD/bbl, Item Domestic naphtha / 2025年3月期上期実績 ¥77,950 /kl / 2025年3月期下期計画 ¥72,000 /kl
Annual DividendAnnual ¥60 per share / Interim ¥30 per share / End of period ¥30 per share
Acquisition of treasury sharesMaximum acquisition amount 150 / Amount unit Hundreds of millions of yen / Maximum number of shares to be acquired 1,200 / Share unit 10,000 shares / Period 2024年11月～2025年3月
New initiatives2024年4月1日付でスマートセグメントとマテリアルセグメントを組織再編, 同日付で脂環式エポキシ・カプロラクトン誘導体をマテリアルからスマートへ、TACをスマートからマテリアルへ移管, 2024年12月に有機半導体事業から撤退, ポリプラスチックスグループのPOM新プラントが2024年11月に稼働開始
Items this document does not state (14)
Gross Profit MarginOperating profit marginSelling, general and administrative expensesUnit price and quantity metricsNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsPayout ratioCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

売上高は、エンジニアリングプラスチックの販売数量増加、電子材料関連市場の需要回復、為替影響などにより増加した。営業利益は、販売数量増加や為替影響があったものの、アセテート・トウの販売数量減少、一酸化炭素プラントのトラブル、減価償却費の増加などにより減少した。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Third-Quarter Financial Results Presentation for the Fiscal Year Ended March 2025 | Daicel Corporation (4202) timely disclosure | Komori